IGCLNSEIndogulf Cropsciences Limited· Fertilizers & AgrochemicalsHighNeutral
Announced Thu, 24 Jul, 2025 · 20:34 IST

Indogulf Cropsciences Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

IGCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.5%Reaction day
₹114.00
prior close
₹113.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.9%-3.6% vs market
Pesticides & Agrochemicals peers, median of 25sector-1.0%-4.6% vs sector

On the reaction day the stock moved 3.6 pts less than Nifty Microcap 250 and 4.6 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.6
10m
-3.5
15m
-2.1
30m
-4.2
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.5-1.9-3.6-1.0-4.6
Next day
-7.6-3.1-4.5-0.3-7.3
2d
-5.4-1.6-3.8+1.8-7.2
3d
-2.5-1.3-1.2+3.0-5.5
4d
-3.1-2.0-1.1+2.1-5.2
5d
-3.1-3.6+0.5-0.4-2.7
1w
-8.6-3.4-5.2+0.4-9.0
15d
-4.2-4.0-0.2-6.0+1.8
1m
-0.6-3.4+2.8-6.9+6.3
2m
-7.4-3.1-4.3-9.2+1.8
3m
-5.0-2.8-2.2-14.6+9.6
UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Indogulf Cropsciences Limited submitted its audited financial results for FY25, which is also its first results filing after listing on NSE and BSE on July 3, 2025 following a recent IPO. The company operates in a single segment, agro-chemicals (technical and formulation). The auditor (Devesh Parekh & Co.) issued an unmodified opinion on both standalone and consolidated results, and the CFO separately declared the same. For the quarter ended March 31, 2025, standalone revenue from operations was about Rs 1,229 million, down from Rs 1,388 million in the same quarter last year. Exceptional items of Rs 13.49 million (gain on sale of fixed assets) were reported in FY25, compared to a Rs 36.65 million loss in FY24. Cash flow statements and balance sheets for both standalone and consolidated positions were also disclosed.

Likely market impact

A clean, unmodified audit opinion is reassuring for a newly listed company, but the Q4 revenue decline and the relatively small scale of operations may draw investor attention. The exceptional item swing (from loss to gain) helps prop up reported profit, so underlying core earnings should be watched.